ImmunityBio, Inc. financial data

Symbol
IBRX on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 392% % 3%
Quick Ratio 14% %
Debt-to-equity -174% % -6.7%
Return On Equity 64% % -26%
Return On Assets -87% % 37%
Operating Margin -316% % 94%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 984,965,179 shares 41%
Common Stock, Shares, Outstanding 984,965,179 shares 41%
Entity Public Float $980,300,000 USD 210%
Common Stock, Value, Issued $98,000 USD 40%
Weighted Average Number of Shares Outstanding, Basic 946,601,000 shares 36%
Weighted Average Number of Shares Outstanding, Diluted 946,601,000 shares 36%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $82,555,000 USD 1026%
Revenue from Contract with Customer, Excluding Assessed Tax $82,555,000 USD 425%
Research and Development Expense $190,144,000 USD -18%
Costs and Expenses $87,691,000 USD 1.5%
Operating Income (Loss) $260,744,000 USD 28%
Nonoperating Income (Expense) $87,949,000 USD 61%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $348,693,000 USD 41%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $348,616,000 USD 41%
Earnings Per Share, Basic 0 USD/shares 56%
Earnings Per Share, Diluted 0 USD/shares 56%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $60,241,000 USD -46%
Marketable Securities, Current $197,572,000 USD 974%
Accounts Receivable, after Allowance for Credit Loss, Current $32,016,000 USD 667%
Inventory, Net $6,703,000 USD 242%
Other Assets, Current $2,513,000 USD 84%
Assets, Current $329,497,000 USD 102%
Property, Plant and Equipment, Net $129,597,000 USD -7%
Operating Lease, Right-of-Use Asset $33,195,000 USD -5%
Intangible Assets, Net (Excluding Goodwill) $16,058,000 USD -15%
Goodwill $910,000 USD 0%
Other Assets, Noncurrent $4,827,000 USD 68%
Assets $518,987,000 USD 42%
Accrued Liabilities, Current $43,602,000 USD 0.01%
Liabilities, Current $57,134,000 USD -6.3%
Operating Lease, Liability, Noncurrent $34,130,000 USD -7.2%
Other Liabilities, Noncurrent $702,000 USD -0.43%
Liabilities $1,042,397,000 USD -6%
Accumulated Other Comprehensive Income (Loss), Net of Tax $4,997,000 USD 4751%
Retained Earnings (Accumulated Deficit) $3,664,702,000 USD -11%
Stockholders' Equity Attributable to Parent $524,319,000 USD 30%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $523,410,000 USD 30%
Liabilities and Equity $518,987,000 USD 42%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $85,905,000 USD 20%
Net Cash Provided by (Used in) Financing Activities $982,000 USD -110%
Net Cash Provided by (Used in) Investing Activities $4,129,000 USD
Common Stock, Shares Authorized 1,350,000,000 shares 0%
Common Stock, Shares, Issued 984,965,179 shares 41%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $82,768,000 USD 37%
Interest Paid, Excluding Capitalized Interest, Operating Activities $15,593,000 USD -35%
Deferred Tax Assets, Valuation Allowance $777,085,000 USD 20%
Deferred Tax Assets, Gross $795,409,000 USD 17%
Operating Lease, Liability $41,446,000 USD -5.4%
Depreciation $13,800,000 USD -13%
Payments to Acquire Property, Plant, and Equipment $1,121,000 USD -11%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $343,722,000 USD 42%
Lessee, Operating Lease, Liability, to be Paid $53,163,000 USD -9.2%
Property, Plant and Equipment, Gross $238,848,000 USD 1.5%
Operating Lease, Liability, Current $7,316,000 USD 4%
Lessee, Operating Lease, Liability, to be Paid, Year Two $10,224,000 USD 5.1%
Lessee, Operating Lease, Liability, to be Paid, Year One $10,899,000 USD -6%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $11,717,000 USD -18%
Lessee, Operating Lease, Liability, to be Paid, Year Three $10,527,000 USD 17%
Deferred Tax Assets, Operating Loss Carryforwards $475,130,000 USD 13%
Preferred Stock, Shares Authorized 20,000,000 shares
Unrecognized Tax Benefits $34,543,000 USD -2.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four $9,915,000 USD 7.2%
Operating Lease, Payments $2,925,000 USD 23%
Amortization of Intangible Assets $2,000,000 USD 0%
Depreciation, Depletion and Amortization $3,829,000 USD -16%
Share-based Payment Arrangement, Expense $37,101,000 USD -2.8%
Interest Expense $72,146,000 USD -40%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares